Total Payments
$3,307
2024 Payments
$450.28
Companies
22
Transactions
57
Medicare Patients
2,903
Medicare Billing
$240,852
Payment Breakdown by Category
Food & Beverage$3,046 (92.1%)
Education$260.89 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,046 | 56 | 92.1% |
| Education | $260.89 | 1 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $487.55 | 11 | $0 (2024) |
| ABBVIE INC. | $332.90 | 4 | $0 (2024) |
| Smith+Nephew, Inc. | $298.80 | 5 | $0 (2019) |
| Stryker Corporation | $295.91 | 3 | $0 (2019) |
| Prodigy Surgical Distribution, Inc. | $260.89 | 1 | $0 (2020) |
| Advanced Oxygen Therapy Inc. | $229.81 | 3 | $0 (2020) |
| Paratek Pharmaceuticals, Inc. | $201.39 | 6 | $0 (2024) |
| KCI USA, Inc | $182.18 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $162.89 | 5 | $0 (2023) |
| Averitas Pharma Inc. | $135.95 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $450.28 | 12 | Averitas Pharma Inc. ($135.95) |
| 2023 | $226.79 | 3 | Horizon Therapeutics plc ($116.63) |
| 2022 | $428.53 | 10 | Organogenesis Inc. ($167.76) |
| 2021 | $112.96 | 2 | AbbVie Inc. ($98.38) |
| 2020 | $487.85 | 7 | Prodigy Surgical Distribution, Inc. ($260.89) |
| 2019 | $668.85 | 9 | Advanced Oxygen Therapy Inc. ($183.53) |
| 2018 | $488.29 | 8 | Stryker Corporation ($249.92) |
| 2017 | $443.34 | 6 | Smith & Nephew, Inc. ($137.50) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/07/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/30/2024 | Organogenesis Inc. | APLIGRAF (Device) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: WOUND CARE | ||||||
| 10/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/19/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ANTIBIOTIC | ||||||
| 05/24/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $58.91 | General |
| Category: FOOT AND ANKLE | ||||||
| 05/16/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ANTIBIOTIC | ||||||
| 05/09/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 04/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/13/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $60.17 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: KRYSTEXXA | ||||||
| 07/20/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $99.63 | General |
| Category: KRYSTEXXA | ||||||
| 03/02/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $110.16 | General |
| Category: ANTIBIOTIC | ||||||
| 09/23/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: KRYSTEXXA | ||||||
| 09/14/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: ANTIBIOTIC | ||||||
| 08/02/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: WOUND CARE | ||||||
| 08/02/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: KRYSTEXXA | ||||||
| 06/07/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: WOUND CARE | ||||||
| 05/11/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $123.15 | General |
| Category: WOUND CARE | ||||||
| 04/07/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $85.11 | General |
| 04/07/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: KRYSTEXXA | ||||||
| 03/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $81.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/24/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 776 | 1,426 | $113,425 | $60,824 |
| 2022 | 14 | 698 | 1,374 | $108,635 | $58,409 |
| 2021 | 14 | 691 | 1,490 | $119,305 | $67,574 |
| 2020 | 15 | 738 | 1,504 | $114,060 | $54,044 |
Total Patients
2,903
Total Services
5,794
Medicare Billing
$240,852
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 331 | $31,445 | $20,367 | 64.8% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 129 | 319 | $19,140 | $10,233 | 53.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 137 | 137 | $19,180 | $9,218 | 48.1% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 40 | 98 | $8,820 | $5,816 | 65.9% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2023 | 96 | 258 | $12,900 | $3,581 | 27.8% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 18 | 42 | $4,410 | $3,075 | 69.7% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 27 | 50 | $3,500 | $2,612 | 74.6% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 45 | 83 | $4,150 | $1,862 | 44.9% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 43 | 63 | $5,040 | $1,347 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $1,560 | $1,245 | 79.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 15 | 16 | $2,400 | $1,149 | 47.9% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 11 | 16 | $880.00 | $317.70 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 260 | $24,700 | $16,651 | 67.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 118 | 118 | $16,520 | $9,147 | 55.4% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 87 | 292 | $17,520 | $8,816 | 50.3% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 41 | 96 | $8,330 | $5,470 | 65.7% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 17 | 54 | $5,670 | $4,097 | 72.3% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2022 | 91 | 278 | $13,900 | $3,930 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 33 | $3,960 | $2,380 | 60.1% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 40 | 100 | $5,000 | $2,188 | 43.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,000 | $1,569 | 52.3% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 46 | 60 | $4,800 | $1,472 | 30.7% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 21 | 28 | $1,860 | $1,271 | 68.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 11 | 11 | $1,650 | $615.90 | 37.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $845.00 | $480.96 | 56.9% |
About Dr. Daniel Smith, DPM
Dr. Daniel Smith, DPM is a Podiatrist healthcare provider based in Liverpool, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417044751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Smith, DPM has received a total of $3,307 in payments from pharmaceutical and medical device companies, with $450.28 received in 2024. These payments were reported across 57 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,046).
As a Medicare-enrolled provider, Smith has provided services to 2,903 Medicare beneficiaries, totaling 5,794 services with total Medicare billing of $240,852. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Podiatrist
- Location Liverpool, NY
- Active Since 10/06/2006
- Last Updated 08/24/2016
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1417044751
Products in Payments
- DALVANCE (Drug) $332.90
- ANCHORAGE (Device) $249.92
- NUZYRA (Drug) $201.39
- KRYSTEXXA (Biological) $198.96
- Santyl (Drug) $194.20
- SNAP (Device) $182.18
- Apligraf (Biological) $179.88
- Puraply (Medical Supply) $167.76
- QUTENZA (Drug) $135.95
- BILAYER WOUND MATRIX (BWM) (Device) $128.05
- KRYSTEXXA (Drug) $125.00
- Apligraf (Device) $104.79
- JUBLIA (Drug) $96.63
- PICO (Device) $73.79
- LAPIPLASTY SYSTEM (Device) $58.91
- VARIAX (Device) $45.99
- APLIGRAF (Device) $35.12
- PLIF (Device) $32.40
- Topaz (Device) $30.81
- KERYDIN (Drug) $20.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Podiatrist Doctors in Liverpool
Adam Bersani, Dpm, DPM
Podiatrist — Payments: $8,885
Podiatrist $8,885
Dr. Robin Johnson, D.p.m, D.P.M
Podiatrist — Payments: $1,164
Podiatrist $1,164
Michael Couch, Dpm, DPM
Podiatrist — Payments: $73.42
Podiatrist $73.42
Dr. Bryan Popovici, Dpm, DPM
Podiatrist — Payments: $30.06
Podiatrist $30.06
Dr. Robert Zucker, Dpm, DPM
Podiatrist
Podiatrist
Dr. Ronald D'amico, Dpm, DPM
Podiatrist
Podiatrist